Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments
- PMID: 32586921
- DOI: 10.1136/annrheumdis-2020-218244
Systematic analysis of COVID-19 infection and symptoms in a systemic lupus erythematosus population: correlation with disease characteristics, hydroxychloroquine use and immunosuppressive treatments
Keywords: glucocorticoids; hydroxychloroquine; lupus erythematosus, systemic.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine.Ann Rheum Dis. 2020 Oct;79(10):1382-1383. doi: 10.1136/annrheumdis-2020-217717. Epub 2020 May 12. Ann Rheum Dis. 2020. PMID: 32398281 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical